华纳药厂:12个药品拟中选国家集采接续采购,涉2024 - 2025年营收

Core Viewpoint - Warner Pharmaceuticals announced participation in the national organized procurement for drugs, with 12 products expected to be selected, including Montmorillonite Powder and Mycophenolate Mofetil Capsules [1] Group 1: Procurement Details - The procurement cycle will last from the actual execution date of the selection results until December 31, 2028 [1] - The projected sales revenue for selected products in 2024 is 176.18 million yuan, accounting for 12.47% of the annual revenue [1] - For the period from January to September 2025, the expected sales revenue is 192.05 million yuan, representing 17.69% of the revenue during the same period [1] Group 2: Future Implications - If procurement contracts are signed and executed, it will expand the sales scale of the products [1] - There is uncertainty regarding the signing of procurement contracts and the execution of market sales [1]